You wrote: "And – Hello again – if Lilly says it can keep profiting on its insulin product despite slashing the price by 70 percent, that means it has been overcharging patients by 70 percent all this time!" I'm no math whiz, but it seems to me that the difference between what they could charge (as low as $9) and what they have been charging (as much as $1000) is about 11,000%! : o )
You wrote: "And – Hello again – if Lilly says it can keep profiting on its insulin product despite slashing the price by 70 percent, that means it has been overcharging patients by 70 percent all this time!"
I'm no math whiz, but it seems to me that the difference between what they could charge (as low as $9) and what they have been charging (as much as $1000) is about 11,000%!
You wrote: "And – Hello again – if Lilly says it can keep profiting on its insulin product despite slashing the price by 70 percent, that means it has been overcharging patients by 70 percent all this time!"
I'm no math whiz, but it seems to me that the difference between what they could charge (as low as $9) and what they have been charging (as much as $1000) is about 11,000%!
: o )